Sara H.
- Country
- Sweden
- Department
- Hematology
Research Overview
- Evaluation of Triptorelin for Ovarian Reserve Preservation in Young Females Undergoing Chemotherapy for Breast Cancer, Leukemia, Lymphomas, and Sarcomas
- R-MINI-CHOP versus R-MINI-CHP in combination with polatuzumab-vedotin, as primary treatment for patients with diffuse large B-cell lymphoma, ≥80 years, or frail ≥75 years – an open label randomized Nordic Lymphoma Group phase III trial - NLG-LBC7 (POLAR BEAR)
Data & Insights
Has run more than one trial at 4 of 51 partner sites.
Specializations
Oncology and Hematology
This investigator specializes in treating various forms of hematologic malignancies and solid tumors, with particular expertise in managing breast cancer and lymphomas.
- Breast Cancer Management
- Diffuse Large B-Cell Lymphoma
- Acute Leukemia
- Sarcomas
Their research extends to various types of sarcomas including osteosarcoma, soft tissue sarcoma, and Ewing sarcoma.
Fertility Preservation
The investigator focuses on reproductive medicine in cancer patients, particularly studying the effects of chemotherapy on ovarian function and fertility preservation strategies.
- Ovarian Reserve Assessment
- Gonadotoxicity Prevention
- Fertility Protection Protocols
Their work includes monitoring Anti-Müllerian Hormone levels to assess ovarian function during cancer treatment.
Treatment Innovation
The investigator explores novel therapeutic approaches in oncology, with emphasis on optimizing treatment protocols for various cancer types.
- Modified Chemotherapy Regimens
- Targeted Cancer Therapies
- Treatment Optimization Strategies
Their research includes evaluating modified treatment protocols for improved patient outcomes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.